17 March 2021 · Global Partnership for Zero Leprosy

World Leprosy Day 2021: Events Around the World

World Leprosy Day is recognized internationally on the last Sunday of January to increase the public awareness of leprosy, also known as Hansen’s disease. This slideshow showcases ways the leprosy community celebrated World Leprosy Day in 2021.

Message for World Leprosy Day 2021: From Yohei Sasakawa, WHO Goodwill Ambassador for Leprosy Elimination

https://www.who.int/news/item/30-01-2021-messages-for-world-leprosy-day-2021

GPZL 2020 Impact Report

Our 2020 impact report highlights our work in COVID-19 response, leprosy research, and country partnerships.

Download

Meeting Notes, February 2021

Global Partnership for Zero Leprosy Leadership Team Meeting – February 2021 Teleconference

Download

A Comprehensive Research Agenda for Zero Leprosy

The Zero Leprosy Research Agenda was published in Infectious Diseases of Poverty. 

Visit site

COVID-19 & Leprosy Resources

Visit the Zero Leprosy COVID-19 hub for the latest advice, resources, and news related to leprosy during the COVID-19 pandemic.

Visit site

The Star July-December 2020

Read the July – December 2020 issue of The Star, radiating the light of truth on Hansen’s disease. The purpose of The Star is to: 1) Promote an educated public opinion of Hansen’s disease. 2.) Serve as advocate for those who have experienced or been impacted by Hansen’s disease. 3) Foster self-empowerment of those who have experienced Hansen’s disease.
Reprinted with permission from The Star, Carville, Louisiana.

Download

Persons affected by leprosy and the COVID-19 global health crisis: a consultative calls report from GPZL’s emergency response Working Group 2

A report from GPZL’s Emergency Response Working Group 2, published in the December 2020 issue of Leprosy Review.

Visit site

GPZL Working Group 1 assesses challenges and a path forward for leprosy during COVID-19

A report from GPZL’s Leprosy Emergency Operations Committee (LEOC), published in the December 2020 issue of Leprosy Review.

Visit site

Meeting Notes, January 2021

Global Partnership for Zero Leprosy Leadership Team Meeting – January 2021 Teleconference

Download

Nitrosamine concerns for rifapentine and rifampicin: Update and FAQs

Update and FAQs from the World Health Organization on recent concerns for rifapentine and rifampicin

Download

Meeting Notes, December 2020

Global Partnership for Zero Leprosy Leadership Team Meeting – December 2020 Teleconference

Download

WHO Technical Guidance: Leprosy/Hansen’s disease contact tracing and post-exposure prophylaxis

“In order to bring down the case detection among leprosy contacts from Point A to Point B, programmes can choose to treat 100 contacts with leprosy and nobody with chemoprophylaxis or provide chemoprophylaxis to all contacts and treat only 43 leprosy patients”. The latter choice is the most obvious for many programmes. This document provides guidance on how to implement contact screening and chemoprophylaxis with single-dose rifampicin. The contents are logically ordered: counselling and obtaining consent, identification and listing of index case, listing of contacts, tracing of contacts, screening of contacts, administration of prophylactic drugs. Managerial aspects to undertake contact screening and chemoprophylaxis are also elaborated, including planning, training, supervision and drug management.

Visit site

Meeting Notes, November 2020

Global Partnership for Zero Leprosy Leadership Team Meeting – November 2020 Teleconference

Download

Meeting Notes: Biannual Leadership Team Conference, October 2020

Global Partnership for Zero Leprosy Leadership Team Biannual Conference – 19 – 21 October 2020 Teleconference

Download

Challenges and a Path Forward for Leprosy during COVID-19: Working Group 1 Report

Working Group 1 found that COVID-19 was having a direct impact on clinics, MDT supply, patient access to care, and NGO activities.

Download

The COVID-19 Crisis and Persons Affected by Leprosy Fact Sheet

Persons affected by leprosy have been especially impacted by the worst consequences of the COVID-19 pandemic. Governments, NGOs, civil society organizations, and organizations of persons affected by leprosy have enacted policies and programmes intended to support persons affected during this crisis, although there are still gaps. The Global Partnership for Zero Leprosy COVID-19 Emergency Response Working Group 2 and UN Special Rapporteur Alice Cruz, gathered data from 100+ persons affected and partners, representing 24 countries on available programmes and resources offering support to persons affected during this time. This fact sheet highlights some of the measures taken by governments and NGOs in the represented countries, and underscores the need for increased support.

Download

Meeting Notes: Governance, September 2020

Global Partnership for Zero Leprosy Leadership Team Meeting on Governance – September 2020 Teleconference

Download

Editorial: Evidence, opportunity, ethics, and the allure of zero leprosy by David G. Addiss

After a decade in which the long-term downward trend in the number of people diagnosed with leprosy (also known as Hansen’s disease) has stalled, there is new momentum toward a vision of zero leprosy. This has been facilitated by scientific advances, particularly related to post-exposure prophylaxis (PEP) for leprosy, and the coming together of the leprosy community in a new Global Partnership for Zero Leprosy.

Visit site

The COVID-19 Crisis and Persons Affected by Leprosy: Questionnaire Results

The economic, social, and health impacts of the COVID-19 pandemic have led to a significant increase in the need for humanitarian aid and social protection measures. Persons affected by leprosy have been especially impacted by the worst consequences of the pandemic, due to preexisting vulnerabilities and economic precarity.
Governments, NGOs, civil society organizations, and organizations of persons affected by leprosy have enacted policies and programmes intended to support persons affected during this crisis, although there are still gaps. To support the effectiveness of these interventions, and to help raise awareness of resources available to persons affected, the Global Partnership for Zero Leprosy’s COVID-19 Emergency Advocacy Working Group and UN Special Rapporteur on the elimination of discrimination against persons affected by leprosy and their family members Alice Cruz, gathered data on available programmes and resources. The following information was gathered through an online questionnaire from 100+ persons affected and partners, representing 24 countries.

The situation in countries regarding COVID-19 is constantly changing. This page will be regularly updated. If you have an update or correction to this information, please contact us.

 

Interested in further information about COVID-19 response in these and other countries?

View these articles from our partners and other organizations:

“Caring Through the Coronavirus Crisis” from The Leprosy Mission Scotland

“Coronavirus Response” from American Leprosy Missions

“COVID-19 Emergency Appeal Update” from Lepra

“COVID-19: Leprosy or tuberculosis patients at risk” from Action Damien

“Liberia: How Ebola prepared us for COVID-19” from effect:hope

“Our response to COVID-19” from the Leprosy Mission International 

Social Protection Responses to COVID-19 Crisis around the World data dashboard from the International Labour Organization

“Supporting Persons Affected by Hansen’s Disease during the Coronavirus Pandemic” from the Sasakawa Health Foundation